Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis
AbstractTo determine the safety and efficacy of 2 consecutive doses of triclabendazole [TCBZ] in the treatment of Schistosoma mansoni infection in human cases infected with both S. mansoni and Fasdola spv we conducted afield survey involving 6314 individuals from 15 villages. The overall prevalence of schistosomiasis alone was 15.8%, of fascioliasis alone 2.2%, and of combined infection 0.7%. Treatment with 2 doses of TCBZ was given to the 49 cases with combined infection. Eight weeks after treatment, the cure rate was 96% for fascioliasis and was 32.7% for schistosorniasis. All schistosomiasis cases cured had a low intensity infection. Liver function tests done before I treatment and 8 weeks after substantiate the safety of 2 doses of TCBZ given to those with combined infection. Administration of TCBZ should precede praziquantel in treatment of combined infection, however TCBZ cannot be recommended for infection with S. mansoni alone
Osman, M.M., Shehab, A.Y., Zaki, A. & Farag, H.F. (2011). Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis. EMHJ - Eastern Mediterranean Health Journal, 17 (4), 266-270, 2011 https://apps.who.int/iris/handle/10665/118114
JournalEMHJ - Eastern Mediterranean Health Journal, 17 (4), 266-270, 2011
MetadataShow full item record
Showing items related by title and subject
Questionnaires pour le dépistage rapide de la schistosomiase en Afrique subsaharienne / Christian Lengeler, Jürg Utzinger et Marcel Tanner Lengeler, Christian; Utzinger, Jürg; Tanner, Marcel (2002)
Bassiouny, H.K.; Hasab, A.A.; El Nimr, N.A.; Al Shibani, L.A.; Al Waleedi, A.A. (World Health Organization, Regional Office for the Eastern Mediterranean, 2014)Schistosomiasis ranks second to malaria in terms of socioeconomic and public health importance in Yemen.This study assessed the validity of a morbidity questionnaire and urine reagent strips as a rapid tool for screening ...